Cargando…

Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity

Pyruvate dehydrogenase kinases (PDKs)-pyruvate dehydrogenase E1α subunit (PDHE1α) axis plays an important role in regulating glucose metabolism in mammals. However, the regulatory function of PDKs-PDHE1α axis in the glucose metabolism of fish is not well known. This study determined whether PDKs inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yuan, Zhou, Wenhao, Li, Ruixin, Limbu, Samwel M., Qiao, Fang, Chen, Liqiao, Zhang, Meiling, Du, Zhen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382415/
https://www.ncbi.nlm.nih.gov/pubmed/36016966
http://dx.doi.org/10.1016/j.aninu.2022.06.011
_version_ 1784769276496838656
author Luo, Yuan
Zhou, Wenhao
Li, Ruixin
Limbu, Samwel M.
Qiao, Fang
Chen, Liqiao
Zhang, Meiling
Du, Zhen-Yu
author_facet Luo, Yuan
Zhou, Wenhao
Li, Ruixin
Limbu, Samwel M.
Qiao, Fang
Chen, Liqiao
Zhang, Meiling
Du, Zhen-Yu
author_sort Luo, Yuan
collection PubMed
description Pyruvate dehydrogenase kinases (PDKs)-pyruvate dehydrogenase E1α subunit (PDHE1α) axis plays an important role in regulating glucose metabolism in mammals. However, the regulatory function of PDKs-PDHE1α axis in the glucose metabolism of fish is not well known. This study determined whether PDKs inhibition could enhance PDHE1α activity, and improve glucose catabolism in fish. Nile tilapia fingerlings (1.90 ± 0.11 g) were randomly divided into 4 treatments in triplicate (30 fish each) and fed control diet without dichloroacetate (DCA) (38% protein, 7% lipid and 45% corn starch) and the control diet supplemented with DCA, which inhibits PDKs through binding the allosteric sites, at 3.75 (DCA3.75), 7.50 (DCA7.50) and 11.25 g/kg (DCA11.25), for 6 wk. The results showed that DCA3.75, DCA7.50 and DCA11.25 significantly increased weight gain, carcass ratio and protein efficiency ratio (P < 0.05) and reduced feed efficiency (P < 0.05) of Nile tilapia. To investigate the effects of DCA on growth performance of Nile tilapia, we selected the lowest dose DCA3.75 for subsequent analysis. Nile tilapia fed on DCA3.75 significantly reduced the mesenteric fat index, serum and liver triglyceride concentration and total lipid content in whole fish, and down-regulated the expressions of genes related to lipogenesis (P < 0.05) compared to the control. The DCA3.75 treatment significantly improved glucose oxidative catabolism and glycogen synthesis in the liver, but significantly reduced the conversion of glucose to lipid (P < 0.05). Furthermore, the DCA3.75 treatment significantly decreased the PDK2/4 gene and protein expressions (P < 0.05), accordingly stimulated PDHE1α activity by decreasing the phosphorylated PDHE1α protein level. In addition, DCA3.75 treatment significantly increased the phosphorylated levels of key proteins involved in insulin signaling pathway and glycogen synthase kinase 3β (P < 0.05). Taken together, the present study demonstrates that PDK2/4 inhibition by using DCA promotes glucose utilization in Nile tilapia by activating PDHE1α and improving insulin sensitivity. Our study helps to understand the regulatory mechanism of glucose metabolism for improving dietary carbohydrate utilization in farmed fish.
format Online
Article
Text
id pubmed-9382415
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-93824152022-08-24 Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity Luo, Yuan Zhou, Wenhao Li, Ruixin Limbu, Samwel M. Qiao, Fang Chen, Liqiao Zhang, Meiling Du, Zhen-Yu Anim Nutr Original Research Article Pyruvate dehydrogenase kinases (PDKs)-pyruvate dehydrogenase E1α subunit (PDHE1α) axis plays an important role in regulating glucose metabolism in mammals. However, the regulatory function of PDKs-PDHE1α axis in the glucose metabolism of fish is not well known. This study determined whether PDKs inhibition could enhance PDHE1α activity, and improve glucose catabolism in fish. Nile tilapia fingerlings (1.90 ± 0.11 g) were randomly divided into 4 treatments in triplicate (30 fish each) and fed control diet without dichloroacetate (DCA) (38% protein, 7% lipid and 45% corn starch) and the control diet supplemented with DCA, which inhibits PDKs through binding the allosteric sites, at 3.75 (DCA3.75), 7.50 (DCA7.50) and 11.25 g/kg (DCA11.25), for 6 wk. The results showed that DCA3.75, DCA7.50 and DCA11.25 significantly increased weight gain, carcass ratio and protein efficiency ratio (P < 0.05) and reduced feed efficiency (P < 0.05) of Nile tilapia. To investigate the effects of DCA on growth performance of Nile tilapia, we selected the lowest dose DCA3.75 for subsequent analysis. Nile tilapia fed on DCA3.75 significantly reduced the mesenteric fat index, serum and liver triglyceride concentration and total lipid content in whole fish, and down-regulated the expressions of genes related to lipogenesis (P < 0.05) compared to the control. The DCA3.75 treatment significantly improved glucose oxidative catabolism and glycogen synthesis in the liver, but significantly reduced the conversion of glucose to lipid (P < 0.05). Furthermore, the DCA3.75 treatment significantly decreased the PDK2/4 gene and protein expressions (P < 0.05), accordingly stimulated PDHE1α activity by decreasing the phosphorylated PDHE1α protein level. In addition, DCA3.75 treatment significantly increased the phosphorylated levels of key proteins involved in insulin signaling pathway and glycogen synthase kinase 3β (P < 0.05). Taken together, the present study demonstrates that PDK2/4 inhibition by using DCA promotes glucose utilization in Nile tilapia by activating PDHE1α and improving insulin sensitivity. Our study helps to understand the regulatory mechanism of glucose metabolism for improving dietary carbohydrate utilization in farmed fish. KeAi Publishing 2022-06-24 /pmc/articles/PMC9382415/ /pubmed/36016966 http://dx.doi.org/10.1016/j.aninu.2022.06.011 Text en © 2022 Chinese Association of Animal Science and Veterinary Medicine. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Luo, Yuan
Zhou, Wenhao
Li, Ruixin
Limbu, Samwel M.
Qiao, Fang
Chen, Liqiao
Zhang, Meiling
Du, Zhen-Yu
Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity
title Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity
title_full Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity
title_fullStr Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity
title_full_unstemmed Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity
title_short Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1α axis and insulin sensitivity
title_sort inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in nile tilapia by regulating pdk2/4-pdhe1α axis and insulin sensitivity
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382415/
https://www.ncbi.nlm.nih.gov/pubmed/36016966
http://dx.doi.org/10.1016/j.aninu.2022.06.011
work_keys_str_mv AT luoyuan inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity
AT zhouwenhao inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity
AT liruixin inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity
AT limbusamwelm inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity
AT qiaofang inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity
AT chenliqiao inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity
AT zhangmeiling inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity
AT duzhenyu inhibitionofpyruvatedehydrogenasekinaseimprovescarbohydrateutilizationinniletilapiabyregulatingpdk24pdhe1aaxisandinsulinsensitivity